Stockholm, Sweden, March 13, 2025 – Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback